{"id":44492,"date":"2022-05-31T12:01:42","date_gmt":"2022-05-31T10:01:42","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/industry-veteran-cuong-do-joins-seneca-therapeutics-inc-advisory-board\/"},"modified":"2022-05-31T12:01:42","modified_gmt":"2022-05-31T10:01:42","slug":"industry-veteran-cuong-do-joins-seneca-therapeutics-inc-advisory-board","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/industry-veteran-cuong-do-joins-seneca-therapeutics-inc-advisory-board\/","title":{"rendered":"Industry Veteran Cuong Do Joins Seneca Therapeutics, Inc. Advisory Board"},"content":{"rendered":"
\n

PHILADELPHIA–(BUSINESS WIRE)–Seneca Therapeutics, Inc. (STI), a clinical-stage biopharmaceutical company dedicated to the development of novel immunotherapies for difficult to treat solid cancers, announced today that Cuong Do, a longtime industry veteran has joined the Seneca Therapeutics Advisory Board. Mr. Do is also an investor in Seneca Therapeutics.\n<\/p>\n

<\/a><\/p>\n

\n\u201cWe are pleased that Cuong has agreed to serve on our Advisory Board,\u201d said James Hussey, CEO of Seneca Therapeutics. \u201cHis insights on the development of SVV Armed Constructs and the SVV Gene Library have been particularly helpful. We look forward to working together in the future.\u201d\n<\/p>\n

\n\u201cI am pleased to join the Seneca Advisory Board,\u201d said Mr. Do. \u201cThe company has incredibly interesting technology. I am looking forward to the upcoming clinical study with SVV-001 and Checkpoint inhibitors in the treatment of neuroendocrine tumors and neuroendocrine carcinoma. I am also excited about the expanding platform for SVV-001 Armed Constructs and SVV Gene Library.\u201d\n<\/p>\n

\nAbout Seneca Therapeutics<\/span><\/b>\n<\/p>\n

\nSeneca Therapeutics was founded to capitalize on the profound tumor specificity of SVV and further the development of SVV-001 in several upcoming clinical trials and the creation and testing of armed derivatives selectively expressing gene product(s) that are inserted into the genome of SVV-001 that create additional anti-tumor effects.\n<\/p>\n

\nForward-Looking Statements<\/span><\/b>\n<\/p>\n

\nThis press release contains \u201cforward-looking statements\u201d concerning the development of Seneca Therapeutics products, the potential benefits and attributes of those products, and the company\u2019s expectations regarding its prospects. Forward-looking statements are subject to risks, assumptions and uncertainties that could cause actual future events or results to differ materially from such statements. These statements are made as of the date of this press release. Actual results may vary. Seneca Therapeutics undertakes no obligation to update any forward-looking statements for any reason.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nPaul Hallenbeck
\n
CSO and President
\n
phallenbeck@senecatherapeutics.com<\/a>\n<\/p>\n

\nJames Hussey
\n
CEO
\n
jhussey@senecatherapeutics.com<\/a>\n<\/p>\n

\nwww.senecatherapeutics.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

PHILADELPHIA–(BUSINESS WIRE)–Seneca Therapeutics, Inc. (STI), a clinical-stage biopharmaceutical company dedicated to the development of novel immunotherapies for difficult to treat solid cancers, announced today that Cuong Do, a longtime industry veteran has joined the Seneca Therapeutics Advisory Board. Mr. Do is also an investor in Seneca Therapeutics. \u201cWe are pleased that Cuong has agreed to … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-44492","6":"format-standard","7":"category-industry"},"yoast_head":"\nIndustry Veteran Cuong Do Joins Seneca Therapeutics, Inc. Advisory Board - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/industry-veteran-cuong-do-joins-seneca-therapeutics-inc-advisory-board\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Industry Veteran Cuong Do Joins Seneca Therapeutics, Inc. Advisory Board - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"PHILADELPHIA–(BUSINESS WIRE)–Seneca Therapeutics, Inc. (STI), a clinical-stage biopharmaceutical company dedicated to the development of novel immunotherapies for difficult to treat solid cancers, announced today that Cuong Do, a longtime industry veteran has joined the Seneca Therapeutics Advisory Board. Mr. Do is also an investor in Seneca Therapeutics. \u201cWe are pleased that Cuong has agreed to ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/industry-veteran-cuong-do-joins-seneca-therapeutics-inc-advisory-board\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-05-31T10:01:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220531005103\/en\/1469586\/21\/Seneca_Therapeutics_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/industry-veteran-cuong-do-joins-seneca-therapeutics-inc-advisory-board\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/industry-veteran-cuong-do-joins-seneca-therapeutics-inc-advisory-board\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Industry Veteran Cuong Do Joins Seneca Therapeutics, Inc. Advisory Board\",\"datePublished\":\"2022-05-31T10:01:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/industry-veteran-cuong-do-joins-seneca-therapeutics-inc-advisory-board\\\/\"},\"wordCount\":317,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/industry-veteran-cuong-do-joins-seneca-therapeutics-inc-advisory-board\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220531005103\\\/en\\\/1469586\\\/21\\\/Seneca_Therapeutics_Logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/industry-veteran-cuong-do-joins-seneca-therapeutics-inc-advisory-board\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/industry-veteran-cuong-do-joins-seneca-therapeutics-inc-advisory-board\\\/\",\"name\":\"Industry Veteran Cuong Do Joins Seneca Therapeutics, Inc. Advisory Board - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/industry-veteran-cuong-do-joins-seneca-therapeutics-inc-advisory-board\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/industry-veteran-cuong-do-joins-seneca-therapeutics-inc-advisory-board\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220531005103\\\/en\\\/1469586\\\/21\\\/Seneca_Therapeutics_Logo.jpg\",\"datePublished\":\"2022-05-31T10:01:42+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/industry-veteran-cuong-do-joins-seneca-therapeutics-inc-advisory-board\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/industry-veteran-cuong-do-joins-seneca-therapeutics-inc-advisory-board\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/industry-veteran-cuong-do-joins-seneca-therapeutics-inc-advisory-board\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220531005103\\\/en\\\/1469586\\\/21\\\/Seneca_Therapeutics_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220531005103\\\/en\\\/1469586\\\/21\\\/Seneca_Therapeutics_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/industry-veteran-cuong-do-joins-seneca-therapeutics-inc-advisory-board\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Industry Veteran Cuong Do Joins Seneca Therapeutics, Inc. Advisory Board\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Industry Veteran Cuong Do Joins Seneca Therapeutics, Inc. Advisory Board - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/industry-veteran-cuong-do-joins-seneca-therapeutics-inc-advisory-board\/","og_locale":"en_US","og_type":"article","og_title":"Industry Veteran Cuong Do Joins Seneca Therapeutics, Inc. Advisory Board - Pharma Trend","og_description":"PHILADELPHIA–(BUSINESS WIRE)–Seneca Therapeutics, Inc. (STI), a clinical-stage biopharmaceutical company dedicated to the development of novel immunotherapies for difficult to treat solid cancers, announced today that Cuong Do, a longtime industry veteran has joined the Seneca Therapeutics Advisory Board. Mr. Do is also an investor in Seneca Therapeutics. \u201cWe are pleased that Cuong has agreed to ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/industry-veteran-cuong-do-joins-seneca-therapeutics-inc-advisory-board\/","og_site_name":"Pharma Trend","article_published_time":"2022-05-31T10:01:42+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220531005103\/en\/1469586\/21\/Seneca_Therapeutics_Logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/industry-veteran-cuong-do-joins-seneca-therapeutics-inc-advisory-board\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/industry-veteran-cuong-do-joins-seneca-therapeutics-inc-advisory-board\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Industry Veteran Cuong Do Joins Seneca Therapeutics, Inc. Advisory Board","datePublished":"2022-05-31T10:01:42+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/industry-veteran-cuong-do-joins-seneca-therapeutics-inc-advisory-board\/"},"wordCount":317,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/industry-veteran-cuong-do-joins-seneca-therapeutics-inc-advisory-board\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220531005103\/en\/1469586\/21\/Seneca_Therapeutics_Logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/industry-veteran-cuong-do-joins-seneca-therapeutics-inc-advisory-board\/","url":"https:\/\/pharma-trend.com\/en\/industry-veteran-cuong-do-joins-seneca-therapeutics-inc-advisory-board\/","name":"Industry Veteran Cuong Do Joins Seneca Therapeutics, Inc. Advisory Board - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/industry-veteran-cuong-do-joins-seneca-therapeutics-inc-advisory-board\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/industry-veteran-cuong-do-joins-seneca-therapeutics-inc-advisory-board\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220531005103\/en\/1469586\/21\/Seneca_Therapeutics_Logo.jpg","datePublished":"2022-05-31T10:01:42+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/industry-veteran-cuong-do-joins-seneca-therapeutics-inc-advisory-board\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/industry-veteran-cuong-do-joins-seneca-therapeutics-inc-advisory-board\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/industry-veteran-cuong-do-joins-seneca-therapeutics-inc-advisory-board\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220531005103\/en\/1469586\/21\/Seneca_Therapeutics_Logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220531005103\/en\/1469586\/21\/Seneca_Therapeutics_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/industry-veteran-cuong-do-joins-seneca-therapeutics-inc-advisory-board\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Industry Veteran Cuong Do Joins Seneca Therapeutics, Inc. Advisory Board"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44492","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=44492"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44492\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=44492"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=44492"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=44492"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}